☆ 4.7 Letter

Combination of a novel HDAC6 inhibitor ACY-241 and anti-PD-L1 antibody enhances anti-tumor immunity and cytotoxicity in multiple myeloma

LEUKEMIA (2018)

Get Full Text
Add to Collection

Journal

LEUKEMIA
Volume 32, Issue 3, Pages 843-846

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/leu.2017.322

Keywords

-

Categories

Oncology Hematology

Funding

  1. National Institutes of Health Specialized Programs of Research Excellence (SPORE) [P50100707, RO1 CA207237, RO1 CA050947]
  2. NATIONAL CANCER INSTITUTE [R01CA050947, R01CA207237, P50CA100707, R01CA178264] Funding Source: NIH RePORTER

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.